Clinical trials of anti-LAG-3/Tim-3 on GBM
| Clin. Trial ID | Disease | Interventions | Status | Phase | Completion data | Result |
|---|---|---|---|---|---|---|
| NCT02658981 | GBM, gliosarcoma recurrent brain neoplasm | Anti-LAG-3 alone in combination with nivol | Recruit | Phase I | Dec. 2020 | Unfinished |
| NCT03493932 | GBM | Anti-LAG-3 combined with nivol | Recruit | Phase I | Jun. 2021 | Unfinished |
| NCT03961971 | GBM, multiforme | Anti-Tim-3 in combination with anti-PD1 and SRS (stereotactic radiosurgery) | Not yet recruit | Phase I | Jun. 2023 | Unfinished |